Abstract:Telomeres are specialized DNA-protein structures that cap linear chromosome ends, preventing telomere erosion and end-to-end fusion. Maintenance of the cap depends in part on TRF2 (Telomeric Repeat-binding Factor-2). Telomere dysfunction induced by loss of TRF2 causes apoptosis in cardiomyocytes and other cell types, but its means of actuating apoptosis is unknown. The Ste20-like kinase, HPK/GCK-like kinase (HGK, MAP4K4) is involved in the TNFα signaling pathway in tumor cells and couples to JNK specifically through the apoptotic TGFβ-activated kinase 1 (TAK1, MAP3K7). Here we postulate: (1) There is a HGK-TAK1-JNK apoptotic pathway in cardiomyocytes, and (2) apoptosis caused by telomere dysfunction may signal through the HGK-TAK1-JNK apoptotic pathway in cardiomyocytes. In mouse myocardium, each of four biological signals for cardiomyocyte apoptosis up-regulated the activity of this proximal MAP kinase, HGK: biomechanical stress, ischemia/reperfusion injury, and gain-of-function mutations for TNFα or Gq. In cultured rat neonatal cardiomyocytes, analogous results were seen using oxidative stress, ceramide, doxorubicin, or Gq. The HGK-induced apoptosis occurred through TAK1 and JNK. Hence, activation of this little-studied MAP4K, HGK, is a highly generalizable response to cardiac apoptotic stress signals, both in vitro and in vivo. An especially noteworthy activator of HGK was telomere dysfunction from interference of normal TRF2 function. Evidence placing TRF2 functionally upstream of the apoptotic HGK-TAK1-JNK signaling module includes: (1) Dominant-negative TRF2 or knockdown of endogenous TRF2 by antisense oligonucleotides activated HGK, (2) Wild-type TRF2 reduced basal HGK activity, and (3) Apoptosis due to dominant-negative TRF2 was largely blocked by dominant-negative mutations of TAK1 or JNK1. Thus, HGK and MAP kinases downstream of HGK have functional importance in apoptosis caused by telomere dysfunction. Furthermore, the activation of the HGK-TAK1-JNK pathway, in turn, markedly reduced TRF2 levels. Dominant-negative mutations of the pathway protected TRF2 loss induced by ceramide, a potent activator of HGK. Because that loss of TRF2 activated the HGK-TAK1-JNK pathway and activation of the HGK-TAK1-JNK pathway induced TRF2 loss, our findings point to the interpretation that telomere dysfunction from loss of TRF2 is reciprocally coupled to activity of the HGK apoptosis pathway. Thus, a positive feedback loop of TRF2 and HGK amplifies the apoptotic signals in cardiomyocytes under stress.

Abstract 1949: the Protein Kinase MAP4K4 is Activated in Failing Human Hearts and Mediates Cardiomyocyte Apoptosis in Experimental Models, in Vitro and in Vivo

Downregulation Of Cypher Induces Apoptosis In Cardiomyocytes Via Akt/P38 Mapk Signaling Pathway

TANK-binding Kinase 1 Alleviates Myocardial Ischemia/reperfusion Injury Through Regulating Apoptotic Pathway.

A MAP4K4-TRF2 Cycle Amplifies Apoptotic Signals

Phosphorylation-dependent Mitochondrial Translocation of MAP4 is an Early Step in Hypoxia-Induced Apoptosis in Cardiomyocytes.

Microtubule Associated Protein 4 Phosphorylation Leads to Pathological Cardiac Remodeling in Mice.

Transforming growth factor β-activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling

Cardiac Muscle Cell Hypertrophy and Apoptosis Induced by Distinct Members of the P38 Mitogen-activated Protein Kinase Family*

The in Vivo Role of P38 MAP Kinases in Cardiac Remodeling and Restrictive Cardiomyopathy.

Mitogen-Activated Protein Kinase Phosphatase-1: A Critical Phosphatase Manipulating Mitogen-Activated Protein Kinase Signaling In Cardiovascular Disease

Cardioprotective C-kit⁺ bone marrow cells attenuate apoptosis after acute myocardial infarction in mice - in-vivo assessment with fluorescence molecular imaging

Abstract 1606: A Novel Cardiac-Specific Isoform of the Cell Cycle-Related Kinase Provides Cardioprotection During Myocardial Ischemia

Cxcr4 Protects Cardiomyocytes From Beta-Adrenergic Stress-Induced Apoptosis

The role of G protein-coupled receptor kinase 4 in cardiomyocyte injury after myocardial infarction

Activation of CaMKIIδC is a Common Intermediate of Diverse Death Stimuli-induced Heart Muscle Cell Apoptosis

MARK4 controls ischaemic heart failure through microtubule detyrosination

Targeted Disruption of Smad4 in Cardiomyocytes Results in Cardiac Hypertrophy and Heart Failure

Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure

Abstract P274: Cardiac-Specific Knockout of Capn4 Attenuates Myocardial Remodeling and Improves Function after Myocardial Infarction in Mice

Transgenic overexpression of active HDAC4 in the heart attenuates cardiac function and exacerbates remodeling in infarcted myocardium.

The CaMK Family Differentially Promotes Necroptosis and Mouse Cardiac Graft Injury and Rejection